No Data
No Data
BrainsWay's Deep TMS Shows Promise in Pain Reduction
BrainsWay Announces The Publication Of Feasibility Clinical Data Evaluating The Analgesic Effects Of Deep Transcranial Magnetic Stimulation In Patients With Peripheral Neuropathic Pain. The Results Were Published In The Neuromodulation Journal, In A...
Express News | Brainsway Reports Promising Feasibility Data Showing Pain Reduction With Deep Tms Therapy
Express News | Jonathan Shulkin Reports 19.1% Stake in Brainsway Ltd as of Nov 5 - SEC Filing
Ladenburg Thalmann Maintains Brainsway(BWAY.US) With Buy Rating, Raises Target Price to $13.4
Brainsway Price Target Raised to $13.40 From $12.60 at Ladenburg
No Data